Search Results - "Brunner AM"

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Authors: Maggioni G Todisco G Sauta E et al.

Corporate Authors: Maggioni G Todisco G Sauta E et al.

Source: HemaSphere [Hemasphere] 2026 Jun 22; Vol. 10 (6), pp. e70406. Date of Electronic Publication: 2026 Jun 22 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Authors: Chung J Vallurupalli M Noel S et al.

Source: Science (New York, N.Y.) [Science] 2026 Apr 09; Vol. 392 (6794), pp. eady5196. Date of Electronic Publication: 2026 Apr 09.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.

Authors: Moore CG Chyong DI Daver N et al.

Source: British journal of haematology [Br J Haematol] 2026 Jul 12. Date of Electronic Publication: 2026 Jul 12.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML.

Authors: Brunner AM Liu Y Garcia JS et al.

Source: Blood advances [Blood Adv] 2026 Jun 30. Date of Electronic Publication: 2026 Jun 30.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Authors: Bewersdorf JP Kewan T Lanino L et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.

Authors: Leonard D Sallman DA Pugh K et al.

Source: Blood advances [Blood Adv] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.

Authors: Filimon S Ghamari A Vakilpour A et al.

Source: JACC. Advances [JACC Adv] 2026 Jun; Vol. 5 (6 Pt 2), pp. 102821.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv Subsets: PubMed not MEDLINE

Chewing the fat: the role of total cholesterol in MPN management.

Authors: Brunner AM; Mass General Brigham Cancer Institute, Harvard Medical School, Boston, MA.

Source: Blood advances [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3744-3745.

Publication Type: Editorial; Comment

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms.

Authors: Gisriel SD Aakash F Bennett JM et al.

Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2025 Oct 01; Vol. 149 (10), pp. 968-976.

Publication Type: Journal Article

Journal Info: Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE

Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.

Authors: Amrein PC Preffer FI Fell G et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jul; Vol. 66 (7), pp. 1234-1244. Date of Electronic Publication: 2025 Mar 12.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

A novel hyperactive BCR::ABL1 ^e6a3 variant confers resistance to combined asciminib plus ponatinib therapy.

Authors: Nardi V Schwieterman J Ansari S et al.

Source: MedRxiv : the preprint server for health sciences [medRxiv] 2026 Apr 24. Date of Electronic Publication: 2026 Apr 24.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Biotechnology innovations for woody perennials research and application.

Authors: Tsai CJ Coleman HD Coleman GD et al.

Source: Tree physiology [Tree Physiol] 2025 Nov 28; Vol. 45 (13), pp. 1-5.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: Canada NLM ID: 100955338 Publication Model: Print Cited Medium: Internet ISSN: 1758-4469 (Electronic) Linking ISSN: 0829318X NLM ISO Abbreviation: Tree Physiol Subsets: MEDLINE; In Process

Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.

Authors: Shimony S Raman HS Flamand Y et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Oct 31; Vol. 14 (1), pp. 191. Date of Electronic Publication: 2024 Oct 31.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.

Authors: Watts J Minden MD Bachiashvili K et al.

Source: Therapeutic advances in hematology [Ther Adv Hematol] 2024 Sep 14; Vol. 15, pp. 20406207241275376. Date of Electronic Publication: 2024 Sep 14 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE

Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia.

Authors: Hantel A Brunner AM Plascak JJ et al.

Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jul 01; Vol. 116 (7), pp. 1178-1184.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome.

Authors: Foran JM Sanz GF Watts JM et al.

Source: Leukemia research [Leuk Res] 2025 Sep; Vol. 156, pp. 107735. Date of Electronic Publication: 2025 Jun 09.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort.

Authors: Guarecuco R Yuen L Roth M et al.

Source: Blood neoplasia [Blood Neoplasia] 2025 Aug 25; Vol. 2 (4), pp. 100162. Date of Electronic Publication: 2025 Aug 25 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference.

Authors: Carraway HE Brunner AM Lai CE et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Aug; Vol. 25 (8), pp. 583-589. Date of Electronic Publication: 2025 Mar 13.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.

Authors: Brunner AM Esteve J Porkka K et al.

Source: American journal of hematology [Am J Hematol] 2024 Feb; Vol. 99 (2), pp. E32-E36. Date of Electronic Publication: 2023 Nov 22.

Publication Type: Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Clinical Utility of Plasma Microbial Cell-Free DNA Surveillance in Neutropenic Patients with Acute Myeloid Leukemia Undergoing Outpatient Chemotherapy: A Case Series.

Authors: Lampou M Trull EC Warren HM et al.

Source: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2025 Jul 05; Vol. 15 (13). Date of Electronic Publication: 2025 Jul 05.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE